Safety Assessment of PEGylated Alkyl Glycerides as Used in Cosmetics.


Journal

International journal of toxicology
ISSN: 1092-874X
Titre abrégé: Int J Toxicol
Pays: United States
ID NLM: 9708436

Informations de publication

Date de publication:
09 2020
Historique:
entrez: 25 9 2020
pubmed: 26 9 2020
medline: 3 9 2021
Statut: ppublish

Résumé

The Expert Panel for Cosmetic Ingredient Safety (Panel) assessed the safety of 60 PEGylated alkyl glycerides. PEGylated alkyl glycerides are mono-, di-, and/or triglycerides that have been modified with ethylene glycol repeat units (in the starting material form as epoxide). Most of the PEGylated alkyl glycerides are reported to function as skin-conditioning agents or surfactants. The Panel reviewed the available animal and clinical data as well as data from the 1999 report for the 5 polyethylene glycol (PEG) glyceryl cocoates and the 2012 report of PEGylated oils, to determine the safety of these ingredients. The Panel concluded these ingredients are safe in the current practices of use and concentration when formulated to be nonirritating; this conclusion supersedes the 1999 conclusion issued on 5 PEG glyceryl cocoate ingredients.

Identifiants

pubmed: 32975154
doi: 10.1177/1091581820951557
doi:

Substances chimiques

Cosmetics 0
Dermatologic Agents 0
Glycerides 0
Surface-Active Agents 0
Polyethylene Glycols 3WJQ0SDW1A

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

26S-58S

Auteurs

Monice M Fiume (MM)

Cosmetic Ingredient Review Senior Director, Washington, DC, USA.

Wilma F Bergfeld (WF)

Expert Panel for Cosmetic Ingredient Safety Member, Washington, DC, USA.

Donald V Belsito (DV)

Expert Panel for Cosmetic Ingredient Safety Member, Washington, DC, USA.

Ronald A Hill (RA)

Expert Panel for Cosmetic Ingredient Safety Member, Washington, DC, USA.

Curtis D Klaassen (CD)

Expert Panel for Cosmetic Ingredient Safety Member, Washington, DC, USA.

Daniel C Liebler (DC)

Expert Panel for Cosmetic Ingredient Safety Member, Washington, DC, USA.

James G Marks (JG)

Expert Panel for Cosmetic Ingredient Safety Member, Washington, DC, USA.

Ronald C Shank (RC)

Expert Panel for Cosmetic Ingredient Safety Member, Washington, DC, USA.

Thomas J Slaga (TJ)

Expert Panel for Cosmetic Ingredient Safety Member, Washington, DC, USA.

Paul W Snyder (PW)

Expert Panel for Cosmetic Ingredient Safety Member, Washington, DC, USA.

Lillian J Gill (LJ)

Cosmetic Ingredient Review Former Director, Washington, DC, USA.

Bart Heldreth (B)

Executive Director, Cosmetic Ingredient Review, Washington, DC, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH